Exact Mass: 695.1692

Exact Mass Matches: 695.1692

Found 24 metabolites which its exact mass value is equals to given mass value 695.1692, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dexylosylbenanomicin A

2-[[(5S,6S)-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]propanoic acid

C34H33NO15 (695.185)


   

Cefotiam hexetil

cefotiam hexetil ester

C27H37N9O7S3 (695.1978)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

Cefotiam hexetil

N-{2-[(1-{[(cyclohexyloxy)carbonyl]oxy}ethoxy)carbonyl]-3-[({1-[2-(dimethylamino)ethyl]-1H-1,2,3,4-tetrazol-5-yl}sulphanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl}-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)ethanimidic acid

C27H37N9O7S3 (695.1978)


   

Pelargonidin 3-(6-succinylglucoside)-5-glucoside

Pelargonidin 3-(6-succinylglucoside)-5-glucoside

C31H35O18 (695.1823)


   

Cyanidin 3,5-di-(6-acetylglucoside)

3,5,7,3,4-Pentahydroxyflavylium 3,5-di- (6-acetylglucoside)

C31H35O18 (695.1823)


   
   
   

(2R)-1-[(2E)-2-[(2S)-6-carboxy-2-carboxylato-2,3-dihydro-1H-pyridin-1-ium-4-ylidene]ethylidene]-6-oxido-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-2,3-dihydroindol-1-ium-2-carboxylate

(2R)-1-[(2E)-2-[(2S)-6-carboxy-2-carboxylato-2,3-dihydro-1H-pyridin-1-ium-4-ylidene]ethylidene]-6-oxido-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-2,3-dihydroindol-1-ium-2-carboxylate

C33H31N2O15- (695.1724)


   

Pteroyl-gamma-glutamyl-gamma-glutamylglutamate

Pteroyl-gamma-glutamyl-gamma-glutamylglutamate

C29H29N9O12-4 (695.1936)


   

8-chloro-7-[(2S,3R,4S,5R)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1H-pyrrole-2-carbonyl)oxyoxan-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-2-oxochromen-4-olate

8-chloro-7-[(2S,3R,4S,5R)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1H-pyrrole-2-carbonyl)oxyoxan-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-2-oxochromen-4-olate

C35H36ClN2O11- (695.2008)


   

quercetin 3-O-(6-O-malonyl)-beta-D-glucoside-7-O-alpha-L-rhamnoside

quercetin 3-O-(6-O-malonyl)-beta-D-glucoside-7-O-alpha-L-rhamnoside

C30H31O19- (695.1459)


   

2,2,2,2-{[4-(9-Anthryl)-2,2:6,2-terpyridine-6,6-diyl]bis(methylenenitrilo)}tetraacetate

2,2,2,2-{[4-(9-Anthryl)-2,2:6,2-terpyridine-6,6-diyl]bis(methylenenitrilo)}tetraacetate

C39H29N5O8-4 (695.2016)


   

Cyanidin 3,5-di-(6-acetylglucoside)

Cyanidin 3,5-di-(6-acetylglucoside)

C31H35O18+ (695.1823)


   

Pelargonidin 3-(6-succinylglucoside)-5-glucoside

Pelargonidin 3-(6-succinylglucoside)-5-glucoside

C31H35O18+ (695.1823)


   

2-[[(5S,6S)-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]propanoic acid

2-[[(5S,6S)-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]propanoic acid

C34H33NO15 (695.185)


   

MI-1061 (TFA)

MI-1061 (TFA)

C32H27Cl2F4N3O6 (695.1213)


MI-1061 TFA is a potent, orally bioavailable, and chemically stable MDM2 (MDM2-p53 interaction) inhibitor (IC50=4.4 nM; Ki=0.16 nM). MI-1061 TFA potently activates p53 and induces apoptosis in the SJSA-1 xenograft tumor tissue in mice. Anti-tumor activity[1].

   

Xamoterol (hemifumarate)

Xamoterol (hemifumarate)

C16H25N3O5.1/2C4H4O4 (695.1904)


Xamoterol hemifumarate is a selective and potent agonist of beta1-adrenergic receptor. Xamoterol hemifumarate has the potential for the research of arrhythmogenesis. Xamoterol hemifumarate has the potential for the investigating the relationship between β1-adrenergic stimulation and IKr[1].

   

Pelargonidin 3-(6'-succinylglucoside)-5-glucoside

Pelargonidin 3-(6'-succinylglucoside)-5-glucoside

C31H35O18 (695.1823)


   

(2r)-2-({hydroxy[(5s,6s)-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-5h,6h-naphtho[1,2-b]anthracen-2-yl]methylidene}amino)propanoic acid

(2r)-2-({hydroxy[(5s,6s)-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-5h,6h-naphtho[1,2-b]anthracen-2-yl]methylidene}amino)propanoic acid

C34H33NO15 (695.185)


   

(2s)-5-hydroxy-1-[(2e)-3-(3-methoxy-4-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-6-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylic acid

(2s)-5-hydroxy-1-[(2e)-3-(3-methoxy-4-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-6-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylic acid

C31H37NO17 (695.2061)


   

5-hydroxy-1-[3-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylic acid

5-hydroxy-1-[3-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylic acid

C31H37NO17 (695.2061)


   

3-{[(2s,3r,4s,5s,6r)-6-{[(3-carboxypropanoyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-2-(4-hydroxyphenyl)-5-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

3-{[(2s,3r,4s,5s,6r)-6-{[(3-carboxypropanoyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-2-(4-hydroxyphenyl)-5-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

[C31H35O18]+ (695.1823)


   

(2s)-5-hydroxy-1-[(2e)-3-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylic acid

(2s)-5-hydroxy-1-[(2e)-3-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylic acid

C31H37NO17 (695.2061)